Abstract
Optical transillumination spectroscopy provides an alternative to mammographic density as a biomarker of breast density and hence cancer risk, permitting frequent and early use thereby extending cancer risk assessment to younger women.
© 2005 Optical Society of America
PDF ArticleMore Like This
Lothar Lüge, Kristina Blyschak, Michelle Simick, and Roberta Jong
5141_278 European Conference on Biomedical Optics (ECBO) 2003
R.A. Weersink, K. M. Blackmore, S. Dick, B.C. Wilson, M. Nielsen, and L. Lilge
ME69 Biomedical Topical Meeting (BIOMED) 2006
Samantha Dick, Kristina Blackmore, Ellen Greenblatt, and Lothar Lilge
BSuE70 Biomedical Optics (BIOMED) 2008